Phases 1 and 2 data support this hypothesis [21–23] showing LI augmentation of CD4+ T (and others) cell infiltrates and CD4/CD8 ratio in the tumor and tumor microenvironment (TME) [21–23]. The gene discussed is CD8A; the disease is neoplasm.